| Use of excised human skin to assess the bioequivalence of topical products TJ Franz, PA Lehman, SG Raney Skin pharmacology and physiology 22 (5), 276-286, 2009 | 180 | 2009 |
| Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN S de Jong, G Chikh, L Sekirov, S Raney, S Semple, S Klimuk, N Yuan, ... Cancer Immunology, Immunotherapy 56, 1251-1264, 2007 | 161 | 2007 |
| Percutaneous absorption in man: in vitro-in vivo correlation PA Lehman, SG Raney, TJ Franz Skin pharmacology and physiology 24 (4), 224-230, 2011 | 150 | 2011 |
| Immune stimulation by a CpG-containing oligodeoxynucleotide is enhanced when encapsulated and delivered in lipid particles B Mui, SG Raney, SC Semple, MJ Hope Journal of Pharmacology and Experimental Therapeutics 298 (3), 1185-1192, 2001 | 127 | 2001 |
| Open flow microperfusion as a dermal pharmacokinetic approach to evaluate topical bioequivalence M Bodenlenz, KI Tiffner, R Raml, T Augustin, C Dragatin, T Birngruber, ... Clinical pharmacokinetics 56, 91-98, 2017 | 105 | 2017 |
| Heat effects on drug delivery across human skin J Hao, P Ghosh, SK Li, B Newman, GB Kasting, SG Raney Expert opinion on drug delivery 13 (5), 755-768, 2016 | 104 | 2016 |
| Pharmacokinetics-based approaches for bioequivalence evaluation of topical dermatological drug products SG Raney, TJ Franz, PA Lehman, R Lionberger, ML Chen Clinical pharmacokinetics 54, 1095-1106, 2015 | 104 | 2015 |
| Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in … KD Wilson, SG Raney, L Sekirov, G Chikh, SD dejong, PR Cullis, YK Tam International immunopharmacology 7 (8), 1064-1075, 2007 | 80 | 2007 |
| A comprehensive approach to qualify and validate the essential parameters of an in vitro release test (IVRT) method for acyclovir cream, 5% KI Tiffner, I Kanfer, T Augustin, R Raml, SG Raney, F Sinner International journal of pharmaceutics 535 (1-2), 217-227, 2018 | 57 | 2018 |
| In vitro–in vivo correlations for nicotine transdermal delivery systems evaluated by both in vitro skin permeation (IVPT) and in vivo serum pharmacokinetics under the influence … SH Shin, S Thomas, SG Raney, P Ghosh, DC Hammell, SS El-Kamary, ... Journal of Controlled Release 270, 76-88, 2018 | 45 | 2018 |
| Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles G Chikh, SD De Jong, L Sekirov, SG Raney, M Kazem, KD Wilson, ... International immunology 21 (7), 757-767, 2009 | 36 | 2009 |
| Navigating sticky areas in transdermal product development C Strasinger, SG Raney, DC Tran, P Ghosh, B Newman, ED Bashaw, ... Journal of Controlled Release 233, 1-9, 2016 | 33 | 2016 |
| On the Road to Development of an in Vitro Permeation Test (IVPT) Model to Compare Heat Effects on Transdermal Delivery Systems: Exploratory Studies with … SH Shin, P Ghosh, B Newman, DC Hammell, SG Raney, HE Hassan, ... Pharmaceutical Research 34, 1817-1830, 2017 | 30 | 2017 |
| In vitro percutaneous absorption of ketoprofen and testosterone: comparison of pluronic lecithin organogel vs. pentravan cream PA Lehman, SG Raney Int. J. Pharm. Compd 16 (3), 248-252, 2012 | 29 | 2012 |
| Characterization of Temperature Profiles in Skin and Transdermal Delivery System When Exposed to Temperature Gradients In Vivo and In Vitro Q Zhang, M Murawsky, T LaCount, J Hao, GB Kasting, B Newman, ... Pharmaceutical research 34, 1491-1504, 2017 | 27 | 2017 |
| Application of Confocal Raman Microscopy for the Characterization of Topical Semisolid Formulations and their Penetration into Human Skin Ex Vivo N Jung, S Namjoshi, Y Mohammed, JE Grice, HAE Benson, SG Raney, ... Pharmaceutical research 39 (5), 935-948, 2022 | 25 | 2022 |
| Cutaneous Pharmacokinetics of Acyclovir Cream 5% Products: Evaluating Bioequivalence with an In Vitro Permeation Test and an Adaptation of Scaled Average … SH Shin, E Rantou, SG Raney, P Ghosh, H Hassan, A Stinchcomb Pharmaceutical Research 37, 1-13, 2020 | 25 | 2020 |
| Generic drug device combination products: Regulatory and scientific considerations SH Choi, Y Wang, DS Conti, SG Raney, R Delvadia, AA Leboeuf, ... International Journal of Pharmaceutics 544 (2), 443-454, 2018 | 23 | 2018 |
| Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity YK Tam, G Chikh, L Sekirov, I Brodsky, SG Raney | 20 | 2005 |
| Multi‐phase multi‐layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin N Patel, JF Clarke, F Salem, T Abdulla, F Martins, S Arora, E Tsakalozou, ... CPT: Pharmacometrics & Systems Pharmacology 11 (8), 1060-1084, 2022 | 19 | 2022 |
priyanka ghoshFDAVerified email at fda.hhs.gov